Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of rosuvastatin calcium

A technology of rosuvastatin calcium and rosuvastatin, which is applied in the field of medicinal chemistry, can solve the problems of high impurity diastereomer, difficulty in reduction or removal, etc. The effect of reducing material introduction

Inactive Publication Date: 2020-05-19
河南豫辰药业股份有限公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the purity of the calcium salt prepared by this method is high, its related impurity diastereoisomers are relatively high, and it is difficult to reduce or remove them.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of rosuvastatin calcium
  • Preparation method of rosuvastatin calcium
  • Preparation method of rosuvastatin calcium

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0028] The preparation method of compound A (reference publication number is the U.S. patent of US20050124639), concrete steps are as follows:

[0029] (1) Put 104g of potassium carbonate, 600ml of dimethyl sulfoxide, and 170g of TPPBr([4-(4-fluorophenyl)-6-isopropyl BFA ((4R-cis)-6-formyl-2,2-dimethyl -1,3-dioxane-4-tert-butyl acetate), adjust the temperature to 70~75°C, react for 2h, monitor the reaction progress with TLC;

[0030] (2) Cool down to 25°C to 35°C, add 1000ml of toluene to dilute, and stir for 30min; filter, add 1000ml of water to the filtrate, stir for 30min, let stand to separate layers, wash the organic layer with 2×1000ml of water, and control the temperature at 50°C to Concentrate under reduced pressure at 70°C; add 750ml of absolute ethanol to the concentrated solution, dissolve at 55-60°C and keep warm for 30 minutes, cool down to 25°C-30°C and stir to precipitate solids, then cool to 11°C and stir to crystallize for 30 minutes, filter with suction, and...

Embodiment 1

[0033] A preparation method of rosuvastatin calcium salt, the specific steps are as follows:

[0034] (1) Protect from light, N 2 Under protective conditions, add compound A 20g (0.0346mol, the structural formula of compound A is: ), acetonitrile 140ml, under the condition of 35~40℃, add dropwise 45ml of hydrochloric acid solution with a concentration of 0.05mol / L, stir for 4h, remove the hydroxyl protecting group (acetonide), cool down to 20~25℃, slowly add dropwise the concentration of 60ml of 5% sodium hydroxide solution was stirred, and the ester was subjected to alkaline hydrolysis for 2 hours to obtain rosuvastatin sodium salt solution. The structural formula of rosuvastatin sodium salt was:

[0035] (2) Concentrate the product of step (1) under reduced pressure to remove the solvent, add 80ml of purified water, stir to dissolve, adjust the pH value to 3-4 with 0.1mol / L hydrochloric acid solution, then extract and separate with 70ml of ethyl acetate, organic The lay...

Embodiment 2

[0038] A preparation method of rosuvastatin calcium salt, the specific steps are as follows:

[0039] (1) Protect from light, N 2 Under protective conditions, add compound A 20g (0.0346mol, the structural formula of compound A is: ), acetonitrile 140ml, under the condition of 35~40℃, add 45ml of hydrochloric acid solution with a concentration of 0.05mol / L dropwise, stir for 3h, remove the hydroxyl protecting group (acetonide), lower the temperature to 20~25℃, slowly add the concentration of 60ml of 5% sodium hydroxide solution was stirred, and the ester was subjected to alkaline hydrolysis for 1 hour to obtain rosuvastatin sodium salt solution. The structural formula of rosuvastatin sodium salt was:

[0040] (2) Concentrate the product of step (1) under reduced pressure to remove the solvent, add 80ml of purified water, stir to dissolve, adjust the pH value to 3-4 with 0.1mol / L hydrochloric acid solution, then extract and separate with 70ml of ethyl acetate, organic The la...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicinal chemistry, and particularly relates to a preparation method of rosuvastatin calcium. The preparation method comprises steps: in an inert atmosphere protection environment, a specific compound is used as a raw material and is reacted under the action of a dilute acid reagent to obtain a hydroxyl protecting group-removed compound; esterolysisis carried out under the action of an alkaline reagent to obtain rosuvastatin sodium; and concentrating is carried out, a proper amount of water is added, the pH value is adjusted to 3-4 by using anacid, extracting is carried out, an obtained organic layer is cooled and crystallized to obtain a rosuvastatin white solid, the white solid is dissolved in pure water, the pH value is adjusted to 8-9by using an alkali, and reacting with a calcium salt aqueous solution is carried out to obtain rosuvastatin calcium with the purity of 99.5% or above and the impurity content of less than 0.1%.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry, and in particular relates to a preparation method of rosuvastatin calcium salt. Background technique [0002] Rosuvastatin calcium: chemical name bis-[E-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidine-5 -yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt, its structure is as follows: [0003] [0004] Rosuvastatin Calcium was developed by Shionogi Company in Osaka, Japan and transferred to Zeneca Company of the United Kingdom in 1998, that is, AstraZeneca (AstraZeneca). , triglyceride and apoprotein concentrations, while increasing the concentration of high-density cholesterol, is the third generation of statins, used for primary hypercholesterolemia and mixed lipodystrophy and homozygous familial hyperlipidemia Comprehensive treatment of cholesterolemia. [0005] The Chinese patent application number CN00803704.3 discloses the preparation meth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/42
CPCC07D239/42Y02P20/55
Inventor 傅收王利叶贾玉香赵强张灿杰王燕旭唐华伟
Owner 河南豫辰药业股份有限公司